Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (8AT)

Market Open
2 Mar, 20:00
XFRA XFRA
2. 41
-0.2
-7.66%
- Market Cap
- P/E Ratio
- Div Yield
2,000 Volume
-1.64 Eps
2.61
Previous Close
Day Range
2.41 2.41
Year Range
0.96 3.81
Want to track 8AT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
8AT earnings report is expected in 65 days (7 May 2026)

Aclaris Therapeutics, Inc. Price History

Download
No Data